Lung Surfactants Market

It is a natural surfactant prepared from the lungs of pigs or cows, which restores breathing through trachea or injection. Mostly used for premature babies.

Lung Surfactants Market contains market size and forecasts of Lung Surfactants in global, including the following market information:

Global Lung Surfactants Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Lung Surfactants Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Lung Surfactants companies in 2021 (%)

The global Lung Surfactants market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intratracheal Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lung Surfactants include Chiesi Farmaceutici, AbbVie, ONY Biotech, Lyomark Pharma, Windtree Therapeutics and Aviva Systems Biology Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Lung Surfactants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lung Surfactants Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lung Surfactants Market Segment Percentages, by Type, 2021 (%)

• Intratracheal
• Injectable

Global Lung Surfactants Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lung Surfactants Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Special Clinic
• Recovery Center

Global Lung Surfactants Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lung Surfactants Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Lung Surfactants revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Lung Surfactants revenues share in global market, 2021 (%)
• Key companies Lung Surfactants sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Lung Surfactants sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Chiesi Farmaceutici
• AbbVie
• ONY Biotech
• Lyomark Pharma
• Windtree Therapeutics
• Aviva Systems Biology Corporation